A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination With Two Other Anti-HIV Drugs
Public ClinicalTrials.gov record NCT00002442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open-Label, Randomized Study of the Efficacy and Safety of Epivir 150 Mg BID Versus Epivir 300 Mg Once-Daily When Administered for 24 Weeks in Combination With FDA-Approved Dosage Regimens of Zerit and Either Crixivan or Viracept in Subjects With HIV-1 Infection
Study identification
- NCT ID
- NCT00002442
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Glaxo Wellcome
- Industry
- Enrollment
- Not listed
Conditions and interventions
Conditions
Interventions
- Indinavir sulfate Drug
- Nelfinavir mesylate Drug
- Lamivudine Drug
- Stavudine Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 1999
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
Started 1999
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AIDS Healthcare Foundation | Los Angeles | California | 90027 | — |
| Palo Alto Veterans Affairs Health Care System | Palo Alto | California | 94304 | — |
| Dupont Circle Physicians Group | Washington D.C. | District of Columbia | 200091104 | — |
| IDC Research Initiative | Altamonte Springs | Florida | 32701 | — |
| North Broward Hosp District | Fort Lauderdale | Florida | 33316 | — |
| Steinhart Medical Associates | Miami | Florida | 33133 | — |
| Northwestern Univ Med School | Chicago | Illinois | 60611 | — |
| Saint Vincents Hosp | New York | New York | 10011 | — |
| St Lukes - Roosevelt Hosp Ctr | New York | New York | 10019 | — |
| MCP Hahnemann Univ Hosp | Philadelphia | Pennsylvania | 19102 | — |
| Southwest Infectious Disease Association / PA | Dallas | Texas | 75225 | — |
| Univ TX Galveston Med Branch | Galveston | Texas | 77550 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00002442 live on ClinicalTrials.gov.